Cargando…

Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema

PURPOSE: Antivascular endothelial growth factor (anti-VEGFs)—bevacizumab is routinely utilised for the treatment of diabetic macular oedema (DME). We plan to evaluate the impact of bevacizumab on the central subfield macular thickness (CSMT) of the treated and untreated eye. METHODS: A sequential gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatri, Anadi, Karki, Pratap, Joshi, Sagun Narayan, Kharel Sitaula, Ranju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895978/ https://www.ncbi.nlm.nih.gov/pubmed/29657972 http://dx.doi.org/10.1136/bmjophth-2017-000102

Ejemplares similares

HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
por: Sharma, Sadhana, et al.
Publicado: (2020)

Combined Intravitreal Bevacizumab And Dexamethasone In Bilateral Lupus Retinopathy
por: Shrestha, Ruchi, et al.
Publicado: (2019)

Influence of glycaemic control on macular thickness in diabetic retinopathy
por: Sharma, Sadhana, et al.
Publicado: (2021)

Panophthalmitis secondary to retained intraocular foreign body amidst a national lockdown during the COVID-19 pandemic: A case series and review of literature
por: Pandit, Kamal, et al.
Publicado: (2022)

Sporadic summer outbreak of SHAPU in even years: Does the pattern match with the usual autumn outbreak?
por: Gurung, Haramaya, et al.
Publicado: (2021)

Challenges of Pediatric Cataract Surgery in a Case of Seasonal Hyperacute Panuveitis (SHAPU)
por: Karki, Pratap, et al.
Publicado: (2021)

Optical coherence tomography patterns of diabetic macular edema and treatment response to bevacizumab: a short-term study
por: Sharma, Sadhana, et al.
Publicado: (2022)

Sub-Foveal Choroidal Thickness In Healthy Nepalese Population
por: Gyawali, Parash, et al.
Publicado: (2019)

Toxoplasma gondii bradyzoites and tachyzoites isolation from vitreous of atypical necrotizing retinitis
por: Kharel(Sitaula), Ranju, et al.
Publicado: (2018)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Youngest reported Seasonal Hyperacute Panuveitis case
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2019)

Moth hair in cornea in a case of seasonal hyperacute panuveitis
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2020)

Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
por: Shibeeb, O'Sam, et al.
Publicado: (2014)

Langerhans cell histiocytosis with hemorrhagic uveitis and exudative retinal detachment
por: Sitaula, Ranju Kharel, et al.
Publicado: (2018)

Does outer retinal layer thickness correlate with the central visual field indices in early dry age-related macular degeneration?
por: Acharya, Sarmila, et al.
Publicado: (2022)

Purtscher-like retinopathy with serous macular detachment in a case of acute pancreatitis: A case report
por: Sharma, Sadhana, et al.
Publicado: (2023)

Vision-related quality of life and psychosocial well-being of patients with episcleritis and scleritis: a neglected essence?
por: Tamrakar, Apurva Ratna, et al.
Publicado: (2021)

Endogenous endophthalmitis in post-COVID-19 patients: a case report
por: Chaudhary, Santosh, et al.
Publicado: (2023)

Outcome of intravitreal bevacizumab injection without pre and postoperative antibiotics
por: Shrestha, Ruchi, et al.
Publicado: (2020)

Role of multimodal imaging in differentiating unilateral APMPPE from unilateral Harada disease – a case report
por: Sharma, Sadhana, et al.
Publicado: (2023)

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
por: Schechet, Sidney A, et al.
Publicado: (2019)

Role of choroidal thickness assessment in unilateral acute anterior uveitis
por: Thapa, Sunil, et al.
Publicado: (2020)

The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review
por: Ford, John A, et al.
Publicado: (2012)

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
por: Newcott, Eric K., et al.
Publicado: (2015)

Optical coherence tomography imaging of macular oedema
por: Trichonas, George, et al.
Publicado: (2014)

Remote examination of exudates-impact of macular oedema
por: Punniyamoorthy, Uma, et al.
Publicado: (2018)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
por: Liu, Lei, et al.
Publicado: (2012)

12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation
por: Barteselli, Giulio, et al.
Publicado: (2014)

Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
por: Foos, William F, et al.
Publicado: (2022)

Perifoveal Microcirculation in Macular Oedema with Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2012)

Transient Cystoid Macular Oedema in Multiple Choroidal Naevi
por: Ziahosseini, Kimia, et al.
Publicado: (2013)

Inflammation and Macular Oedema after Pars Plana Vitrectomy
por: Romano, Vito, et al.
Publicado: (2013)

Conversion of Central Subfield Thickness Measurements of Diabetic Macular Edema Across Cirrus and Spectralis Optical Coherence Tomography Instruments
por: Sun, Jennifer K., et al.
Publicado: (2021)

Short-term and long-term results after intravitreal bevacizumab therapy for macular oedema in branch retinal vein occlusion
por: Pidro, Ajla, et al.
Publicado: (2022)

Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
por: Gildea, David, et al.
Publicado: (2023)

Role of lupus retinopathy in systemic lupus erythematosus
por: Kharel (Sitaula), Ranju, et al.
Publicado: (2016)

Combination of Intravitreal Bevacizumab and Topical Dorzolamide versus Intravitreal Bevacizumab Alone for Diabetic Macular Edema: A Randomized Contralateral Clinical Trial
por: Fazel, Farhad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lpqu31dd3rmigouin2ivpgoes